INVESTMENTS IN INNOVATION
Elephas Biosciences Corporation
918 Deming Way, Suite 101
Elephas is building an instrument platform that will inform how clinicians treat cancer patients. The platform will interrogate live human tumors ex vivo. While the system is being designed to help determine the best cancer therapy for each patient, there will be significant potential applications of the platform for biopharma companies developing oncology drugs and for cancer researchers.